Current controlled trials in cardiovascular medicine / / BioMed Central, PubMed Central.

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:London : : BioMed Central,, [2000]
Publication history:Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005).
Language:English
Physical Description:1 online resource
Notes:
  • Refereed/Peer-reviewed
  • Title from contents screen (viewed July 2, 2002).
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993573745204498
lccn 2002252924
ctrlnum (DE-599)ZDB2040523-6
(OCoLC)48407034
(CKB)111018467304014
(CONSER)--2002252924
(NjHacI)99111018467304014
(EXLCZ)99111018467304014
collection bib_alma
record_format marc
spelling Current controlled trials in cardiovascular medicine (Online)
CURR CONTROL TRIALS CARDIOVASC MED
Curr control trials cardiovasc med
Curr. control. trials, Cardiovasc. med. (Online)
Current controlled trials. Cardiovascular medicine (Online)
Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central.
CCTCVM
[London] : BioMed Central, 2000-2005.
London : BioMed Central, [2000]
1 online resource
Annual
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005).
Refereed/Peer-reviewed
Unrestricted online access star
Title from contents screen (viewed July 2, 2002).
Chemical abstracts 0009-2258
Vol. 1 complete in three issues.
Latest issue consulted: Vol. 2, no. 6 (2001).
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.
Cardiology Periodicals.
Clinical trials Periodicals.
Cardiology. fast (OCoLC)fst00847121
Clinical trials. fast (OCoLC)fst00864429
Cardiovascular Diseases therapy.
Cardiovascular Diseases physiopathology.
Cardiovascular Diseases
Periodicals.
Controlled Clinical Trial.
Periodicals. fast (OCoLC)fst01411641
TRIALS (CKB)1000000000026276 (DLC)2006243052
1468-6708
National Institutes of Health (U.S.). PubMed Central.
language English
format Journal
author2 National Institutes of Health (U.S.). PubMed Central.
author_facet National Institutes of Health (U.S.). PubMed Central.
National Institutes of Health (U.S.). PubMed Central.
author2_role TeilnehmendeR
author_corporate National Institutes of Health (U.S.). PubMed Central.
title Current controlled trials in cardiovascular medicine /
spellingShingle Current controlled trials in cardiovascular medicine /
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.
title_short CURR CONTROL TRIALS CARDIOVASC MED
title_full Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central.
title_fullStr Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central.
title_full_unstemmed Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central.
title_auth Current controlled trials in cardiovascular medicine /
title_alt Current controlled trials in cardiovascular medicine (Online)
title_new Current controlled trials in cardiovascular medicine /
title_sort current controlled trials in cardiovascular medicine /
publisher BioMed Central,
publishDate 2000
physical 1 online resource
dateSpan Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005).
contents Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.
issn 1468-6694
1468-6708
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC681
callnumber-sort RC 3681 A1 C877 42001
genre Periodicals.
Controlled Clinical Trial.
Periodicals. fast (OCoLC)fst01411641
genre_facet Periodicals.
Controlled Clinical Trial.
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616
dewey-sort 3616
dewey-raw 616
dewey-search 616
oclc_num 48407034
work_keys_str_mv UT currentcontrolledtrialsincardiovascularmedicineonline
AT nationalinstitutesofhealthuspubmedcentral currentcontrolledtrialsincardiovascularmedicine
AT nationalinstitutesofhealthuspubmedcentral cctcvm
status_str n
ids_txt_mv (DE-599)ZDB2040523-6
(OCoLC)48407034
(CKB)111018467304014
(CONSER)--2002252924
(NjHacI)99111018467304014
(EXLCZ)99111018467304014
carrierType_str_mv cr
is_hierarchy_title Current controlled trials in cardiovascular medicine /
author2_original_writing_str_mv noLinkedField
_version_ 1796652595106807808
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200565-a-4500</leader><controlfield tag="001">993573745204498</controlfield><controlfield tag="005">20240112213020.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-cnu||||||||</controlfield><controlfield tag="008">011112d20002005enkuu-pso-----0----0eng-c</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2002252924</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB0E1444</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">2040523-6</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">1468-6694</subfield></datafield><datafield tag="030" ind1=" " ind2=" "><subfield code="a">CCTCD6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2040523-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48407034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)111018467304014</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2002252924</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)99111018467304014</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)99111018467304014</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC681.A1</subfield><subfield code="b">.C877 2001</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="130" ind1="0" ind2=" "><subfield code="a">Current controlled trials in cardiovascular medicine (Online)</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">CURR CONTROL TRIALS CARDIOVASC MED</subfield></datafield><datafield tag="210" ind1="0" ind2="0"><subfield code="a">Curr control trials cardiovasc med</subfield></datafield><datafield tag="210" ind1="0" ind2=" "><subfield code="a">Curr. control. trials, Cardiovasc. med.</subfield><subfield code="b">(Online)</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Current controlled trials. Cardiovascular medicine</subfield><subfield code="b">(Online)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current controlled trials in cardiovascular medicine /</subfield><subfield code="c">BioMed Central, PubMed Central.</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">CCTCVM</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">[London] :</subfield><subfield code="b">BioMed Central,</subfield><subfield code="c">2000-2005.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">BioMed Central,</subfield><subfield code="c">[2000]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="310" ind1=" " ind2=" "><subfield code="a">Annual</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="0" ind2=" "><subfield code="a">Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from contents screen (viewed July 2, 2002).</subfield></datafield><datafield tag="510" ind1="0" ind2=" "><subfield code="a">Chemical abstracts</subfield><subfield code="x">0009-2258</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Vol. 1 complete in three issues.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Vol. 2, no. 6 (2001).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiology</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiology.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00847121</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00864429</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">therapy.</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">physiopathology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular Diseases</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodicals.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Controlled Clinical Trial.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="785" ind1="0" ind2="0"><subfield code="t">TRIALS</subfield><subfield code="w">(CKB)1000000000026276</subfield><subfield code="w">(DLC)2006243052</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="x">1468-6708</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Institutes of Health (U.S.).</subfield><subfield code="b">PubMed Central.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-02-25 02:47:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-02-25 23:26:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5341823350004498&amp;Force_direct=true</subfield><subfield code="Z">5341823350004498</subfield><subfield code="m"> Available from 2000 until 2013.</subfield><subfield code="b">Available</subfield><subfield code="8">5341823350004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5341823350004498</subfield><subfield code="A">2000</subfield><subfield code="B">2013</subfield></datafield></record></collection>